Access to Intra-Arterial Therapies for Acute Ischemic Stroke: An Analysis of the US Population

References

1. ↵
   NINDS rt-PA Stroke Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587

   CrossRefPubMedWeb of Science
2. ↵
   Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–2011

   CrossRefPubMedWeb of Science
3. ↵
   Leary MC, Saver JL, Gobin YP, et al. Beyond tissue plasminogen activator: mechanical intervention in acute stroke. Ann Emerg Med 2003;41:838–846

   CrossRefPubMed
4. ↵
   del Zoppo GJ. Thrombolytic therapy in the treatment of stroke. Drugs 1997;54:90–98

   PubMed
5. ↵
   Ginsberg MD. The validity of rodent brain-ischemia models is self-evident. Arch Neurol 1996;53:1065–1067

   CrossRefPubMedWeb of Science
6. ↵
   Memezawa H, Minamisawa H, Smith ML, Siesjo BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 1992;89:67–78

   CrossRefPubMedWeb of Science
7. ↵
   Furlan M, Marchal G, Viader F, et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996;40:216–226

   CrossRefPubMedWeb of Science
8. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418–426

   Abstract/FREE Full Text
9. ↵
   Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999;30:2043–2052

   Abstract/FREE Full Text
10. ↵
    Nilasena DS, Kresowik TF, Wiblin RT, et al. Assessing patterns of tPA use in acute stroke [Abstract]. Stroke 2002;33:354
11. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18–22

    Abstract/FREE Full Text
12. ↵
    Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study—a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019–2026

    CrossRefPubMedWeb of Science
13. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–1251

    CrossRefPubMedWeb of Science
14. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–1025

    CrossRefPubMedWeb of Science
15. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 1996;276:961–966

    CrossRefPubMedWeb of Science
16. Thrombolytic therapy with streptokinase in acute ischemic stroke: the Multicenter Acute Stroke Trial–Europe Study Group. N Engl J Med 1996;335:145–150

    CrossRefPubMedWeb of Science
17. ↵
    Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke: Multicentre Acute Stroke Trial–Italy (MAST-I) Group. Lancet 1995;346:1509–1514

    CrossRefPubMedWeb of Science
18. ↵
    Saver JL. Intra-arterial thrombolysis [Suppl]. Neurology 2001;57:S58–S60

    Abstract/FREE Full Text
19. ↵
    Furlan AJ. Acute stroke therapy: beyond i.v. tPA. Cleve Clin J Med 2002;69:730–734

    Abstract/FREE Full Text
20. ↵
    Marler JR, Winters Jones P, Emr M. The National Institute of Neurological Disorders and Stroke: Proceedings of National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda: National Institute of Neurological Disorders and Stroke,1997
21. ↵
    Scott P, Temovsky CJ, Lawrence K, et al. Analysis of Canadian population with geographic access to intravenous thrombolysis for acute ischemic stroke [Abstract]. Stroke 1998;29:289
22. ↵
    Scott P, Lowell MJ, Longstreth K. Analysis of US population with geographic access to interventional neuroradiology and intra-arterial thrombolysis for acute ischemic stroke [Abstract]. Stroke 1997;28:266
23. ↵
    Smith JS Jr, Smith BJ, Pletcher SE, et al. When is air medical service faster than ground transportation? Air Med J 1993;12:258–261

    CrossRefPubMed
24. Kasner SE, Chalela JA, Luciano JM, et al. Reliability and validity of estimating the NIH Stroke Scale from medical records [Abstract]. Neurology 1999;52:A149
25. ↵
    Silliman SL, Quinn B, Huggett V, Merino JG. Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke 2003;34:729–733

    Abstract/FREE Full Text
26. ↵
    Nicholl JP, Beeby NR, Brazier JE. A comparison of the costs and performance of an emergency helicopter and land ambulances in a rural area. Injury 1994;25:145–153

    CrossRefPubMed
27. ↵
    Intraarterial thrombolysis: ready for prime time? Executive Committee of the ASITN: American Society of Interventional and Therapeutic Neuroradiology. AJNR Am J Neuroradiol 2001;22:55–58

    FREE Full Text
28. ↵
    Wojner AW, Persse D, Alexandrov AV, Grotta J. Weaving a web for stroke treatment: the Houston Paramedic/Emergency Stroke Treatment Outcomes Study (HoPSTO) [Abstract]. Stroke 2003;34:248A
29. ↵
    Merino JG, Silver B, Wong E, et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002;33:141–146

    Abstract/FREE Full Text
30. ↵
    Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers: Brain Attack Coalition. JAMA 2000;283:3102–3109

    CrossRefPubMedWeb of Science
31. ↵
    Kidwell CS, Shephard T, Tonn S, et al. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources. Neurology 2003;60:1452–1456

    Abstract/FREE Full Text
32. ↵
    Kidwell CS, Starkman S, Eckstein M, et al. Identifying stroke in the field: prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS). Stroke 2000;31:71–76

    Abstract/FREE Full Text
33. ↵
    Kothari R, Hall K, Brott T, Broderick J. Early stroke recognition: developing an out-of-hospital NIH stroke scale. Acad Emerg Med 1997;4:986–990

    PubMedWeb of Science
34. ↵
    Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71–76

    Abstract/FREE Full Text